- Location
therapeutic antibody
"-
AnaptysBio Has Commenced an Antibody Development Program with Momenta Pharmaceuticals
Dec 20, 2013US-based privately-held therapeutic antibody firm AnaptysBio has commenced an antibody development program with Momenta Pharmaceuticals, focused on the development of new antibodies against a therapeutically relevant target. Both the ...
-
Innate Pharma Has Started a New Program Named Iph43, to Develop an Anti-Mica
Nov 20, 2013Innate Pharma has started a new program named IPH43, to develop an anti-MICA therapeutic antibody in oncology. The program is the newest to emerge from the company's discovery platform. MICA, which is highly polymorphic ligand of the NK ...
Tags: Innate Pharma, Anti-Mica Antibody
-
Heptares Supplies Delivered The First Stabilised G Protein-Coupled Receptor to Morphosys
Oct 12, 2013US-based drug discovery and development firm, Heptares Therapeutics has delivered the first stabilised G protein-coupled receptor (GPCR) called 'StaR' to MorphoSys for antibody discovery as part of their antibody therapeutics alliance. ...
Tags: Heptares Therapeutics, drug
-
Adimab and Innovent to Discover, Develop and Commercialise an Antibody-Based Therapeutic
Aug 22, 2013Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab antibody discovery and optimization platform, against a selected specific target. All initial product development ...
Tags: Adimab, Antibody-Based Therapeutic
-
Novartis Has Received an Approval From The European Commission for Its Lucentis
Jul 10, 2013Novartis has received an approval from the European Commission for its Lucentis (ranibizumab) to treat patients with visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV). Lucentis is a ...
-
Lpath Has Won a US patent
May 31, 2013Lpath has won a US patent covering methods of using monoclonal antibodies for the treatment and prevention of ocular conditions, including wet age-related macular degeneration (AMD). The patent includes the use of monoclonal antibodies, ...
-
Astellas Pharma and Ambrx Have Collaborated to Discover and Develop New ADCs
Apr 5, 2013Astellas Pharma and Ambrx have collaborated to discover and develop new antibody drug conjugates (ADCs) for the targeted delivery of drugs into cancer tissues. Ambrx will use site-specific conjugation technology in addition to proprietary ...
Tags: Antibody Drug, Health, Medicine
-
Morphosys and Heptares to Develop Antibody Therapeutics Against GPCRs
Feb 20, 2013MorphoSys and Heptares Therapeutics have signed a research deal to develop antibody therapeutics against G protein-coupled receptors (GPCRs). According to the deal, Heptares will produce stabilized receptors (StaRs) for MorphoSys proposed ...
Tags: antibody therapeutics, Heptares Therapeutics, GPCR disease
-
AIMM Therapeutics Collaborated to Develop Oral Diagnostic and Therapeutic Antibodies
Dec 27, 2012Therapeutic antibody company AIMM Therapeutics has collaborated with Italy-based Cosmo Pharmaceuticals to develop oral diagnostic and therapeutic antibodies for gastrointestinal diseases, including colon carcinoma. As part of the ...
-
Kaneka Has Unveiled KANEKA KanCapA
Dec 5, 2012Kaneka has unveiled KANEKA KanCapA, a new protein A chromatography resin to purify therapeutic antibodies. Protein A chromatography resin is widely used to produce antibodies due to its high affinity and excellent selectivity for ...
-
Xbiotech Launch to Evaluate Overall Survival in Advanced Colorectal Cancer Patients
Oct 5, 2012XBiotech has received FDA fast track designation for its anti-cachexia drug Xilonix, a first-in-class True Human antibody. Xilonix blocks an inflammatory substance (IL-1a) produced by the body in response to tumor growth, which plays a ...
